NMPA Approval

Latanoprost and Timolol Maleate Eye Drops

Approval Number

国药准字HJ20171093

Registration Date

March 21, 2022

Previous Approval Numbers

H20171093

Drug Information

Generic Name

拉坦噻吗滴眼液

Dosage Form

眼用制剂

Strength

每1ml 溶液含50μg拉坦前列素和6.8mg马来酸噻吗洛尔

Drug Type

化学药品

Registration Date

March 21, 2022

Expiry Date

March 20, 2027

Company Address

Terhulpsesteenweg 6A, B-1560 Hoeilaart

Company Address

Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium

Empowering clinical research with data-driven insights and AI-powered tools.

拉坦噻吗滴眼液 - NMPA 批准文号 | MedPath